TriangleFOR PATIENTS · SOURCE READING
Treatment Option Overview
Source: Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Continue within this section
Key Points →There are different types of treatment for patients with myelodysplastic syndromes. →Treatment for myelodysplastic syndromes includes supportive care, drug therapy, and stem cell transplant. →The following types of treatment are used: →New types of treatment are being tested in clinical trials. →Treatment for myelodysplastic syndromes may cause side effects. →Patients may want to think about taking part in a clinical trial. →Patients can enter clinical trials before, during, or after starting their treatment. →Follow-up tests may be needed. →
Preserved source evidence · Independent clinical review pending · Not medical advice